Prem Watsa Xeris Biopharma Holdings, Inc. Transaction History
Fairfax Financial Holdings LTD
- $1.49 Billion
- Q4 2024
A detailed history of Prem Watsa (Fairfax Financial Holdings LTD) transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Fairfax Financial Holdings LTD holds 139,687 shares of XERS stock, worth $515,445. This represents 0.03% of its overall portfolio holdings.
Number of Shares
139,687
Previous 170,937
18.28%
Holding current value
$515,445
Previous $487,000
2.87%
% of portfolio
0.03%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding XERS
# of Institutions
163Shares Held
61.5MCall Options Held
34.2KPut Options Held
21.7K-
Black Rock Inc. New York, NY10.3MShares$38.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$29.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.35MShares$12.4 Million0.0% of portfolio
-
State Street Corp Boston, MA3.34MShares$12.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.88MShares$10.6 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $502M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...